Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axogen (AXGN) Gains from Sales and Divestitures (2017 - 2020)

Historic Gains from Sales and Divestitures for Axogen (AXGN) over the last 4 years, with Q3 2020 value amounting to $168311.0.

  • Axogen's Gains from Sales and Divestitures changed N/A to $168311.0 in Q3 2020 from the same period last year, while for Sep 2020 it was $168311.0, marking a year-over-year change of. This contributed to the annual value of $86405.0 for FY2019, which is 110846.15% up from last year.
  • As of Q3 2020, Axogen's Gains from Sales and Divestitures stood at $168311.0.
  • Over the past 5 years, Axogen's Gains from Sales and Divestitures peaked at $168311.0 during Q3 2020, and registered a low of $7150.0 during Q4 2017.
  • Over the past 4 years, Axogen's median Gains from Sales and Divestitures value was $86405.0 (recorded in 2019), while the average stood at $82980.4.
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first changed by 0.0% in 2018, then surged by 110846.15% in 2019.
  • Axogen's Gains from Sales and Divestitures (Quarter) stood at $7150.0 in 2017, then changed by 0.0% to $7150.0 in 2018, then skyrocketed by 1108.46% to $86405.0 in 2019, then soared by 94.79% to $168311.0 in 2020.
  • Its Gains from Sales and Divestitures stands at $168311.0 for Q3 2020, versus $145886.0 for Q2 2020 and $86405.0 for Q4 2019.